Disease: Idiopathic thrombocytopenic purpura
- A Case of Myosin Heavy Chain 9-Related Disorder Following Splenectomy Due to Misdiagnosis of Idiopathic Thrombocytopenic Purpura
- A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry
- A prospective cohort study to identify clinical diagnostic and prognostic markers of primary immune thrombocytopenia in dogs
- A Review on Romiplostim Mechanism of Action and the Expressive Approach in <em>E. coli</em>
- Acute primary CMV infection complicated by pneumonitis and ITP in young immunocompetent woman in a regional Queensland Hospital
- ADAMTS-13 conformation influences autoimmune recognition in immune thrombotic thrombocytopenic purpura
- Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management
- Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase
- An infant with severe neonatal immune thrombocytopenia and gradual resumption of breastfeeding
- Assessing uptake of the core outcome set in clinical trials for immune thrombocytopenia: A cross-sectional analysis
- Autoimmune Cytopenias Are Highly Associated with Inborn Errors of Immunity and They May Be the Initial Presentations in Cases without Severe Infections
- Autoimmune cytopenias in children: When to think of primary immunodeficiency?
- Avatrombopag for adults with early versus chronic immune thrombocytopenia
- Avatrombopag-induced lactic acidosis in a patient with severe thrombocytopenia
- B-cell responses to ITP treatments
- Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine
- Can low-dose intravenous immunoglobulin be an alternative to high-dose intravenous immunoglobulin in the treatment of children with newly diagnosed immune thrombocytopenia: a systematic review and meta-analysis
- Child with refractory thrombocytopenia born to a mother with immune thrombocytopenia
- Concomitant presentation of thrombotic thrombocytopenic purpura, immune thrombocytopenia, and autoimmune hemolytic anemia in a patient with newly diagnosed systemic lupus erythematosus
- Congenital thrombotic thrombocytopenic purpura diagnosed in adulthood after repeated thrombocytopenia since neonatal period
- Conspicuous Peripheral Retinal Hemorrhages with a Relatively Preserved Posterior Pole in Immune Thrombocytopenic Purpura
- Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options
- Damage-associated cellular markers in the clinical and pathogenic profile of vaccine-induced immune thrombotic thrombocytopenia
- Dapsone for paediatric chronic immune thrombocytopenia: Short report from a tertiary centre in South India
- Decreased Expression of IL-35 and Its Receptor Contributes to Impaired Megakaryopoiesis in the Pathogenesis of Immune Thrombocytopenia
- Difficult-to-treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN-France registry
- Distinguishing thrombotic thrombocytopenic purpura from primary immune thrombocytopenia accompanied by anemia using the carbon monoxide breath test
- E3 ubiquitin ligase casitas B-lineage lymphoma-b modulates T-cell anergic resistance via phosphoinositide 3-kinase signaling in patients with immune thrombocytopenia
- Effects of <em>Ziyin Liangxue</em> Formula Combined with Prednisone on Immune Function and ST2/IL-33 Pathway in Mice with Immune Thrombocytopenia
- Effects of canine influenza infection and DA2PP vaccination on the development of platelet-associated immunoglobulins and platelet counts in dogs
- Efficacy and safety of human umbilical cord-derived mesenchymal stem cells in the treatment of refractory immune thrombocytopenia: a prospective, single arm, phase I trial
- Efgartigimod hilft bei Immunthrombozytopenie
- Eltrombopag Use in Children with Persistent and Chronic Primary Immune Thrombocytopenia in a Portuguese Pediatric Center
- Evaluation of the safety profile of the quadrivalent vaccine against human papillomavirus in the risk of developing autoimmune, neurological, and hematological diseases in adolescent women in Colombia
- Evaluation of vitamin D status in adult patients with newly diagnosed immune thrombocytopenia
- Excellent response to treatment with hydroxychloroquine in pediatric patients with SLE-related immune thrombocytopenia
- Expression of MicroRNA-3162-3p in Different Clinical Stages of Children with Primary Immune Thrombocytopenia and Its Significance
- Face validity of the Kids' ITP Tools (KIT) in the era of thrombopoietin receptor agonists
- Flow cytometry for comprehensive assessment of platelet functional activity in response to ADP stimulation
- Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P's) for anti-PF4 diseases
- Hemostatic balance between pro- and anticoagulant is maintained during glucocorticoid treatment
- HIF-1α induced by hypoxic condition regulates Treg/Th17 axis polarization in chronic immune thrombocytopenia
- How to manage ITP with life-threatening bleeding
- Human Fc gamma receptor IIIA blockade inhibits platelet destruction in a humanized murine model of ITP
- Identification of metabolism-related key genes as potential biomarkers for pathogenesis of immune thrombocytopenia
- Idiopathic Thrombocytopenic Purpura: Current Limitations and Management
- Immune thrombocytopaenic purpura following COVID-19 infection masquerading as senile purpura
- Immune thrombocytopenia (ITP) in pregnancy
- Immune Thrombocytopenic Purpura Associated With Systemic Lupus Erythematosus, Helicobacter pylori, and Hepatitis B
- Immune-mediated thrombocytopenia and IL-6-mediated thrombocytosis observed in idiopathic multicentric Castleman disease
- Important Recommendations Regarding the Test-and-Treat Strategy for <em>Helicobacter pylori</em> Infection in Children
- Impurity assessment, development and validation of an RP-HPLC method for the determination of eleven potential impurities of eltrombopag precursor
- Incidence and risk factors of systemic lupus erythematosus in patients with primary immune thrombocytopenia: a systematic review and meta-analysis
- Is Immune Thrombocytopenia and its Treatment Associated with Sarcopenia?
- Long-term eltrombopag in children with chronic immune thrombocytopenia: A single-centre extended real-life observational study in China
- Long-term treatment with fostamatinib in Japanese patients with primary immune thrombocytopenia: An open-label extension study following a phase 3 placebo-controlled, double-blind, parallel-group study
- Long-term treatment with rilzabrutinib in patients with immune thrombocytopenia
- Lymphocyte subpopulations: a potential predictor of a response in patients with immune thrombocytopenia
- Machine learning models developed and internally validated for predicting chronicity in pediatric immune thrombocytopenia
- Medical consult: aHUS, TTP? How to distinguish and what to do
- Modified osteochondral autograft transplantation for steroid-induced osteonecrosis of femoral head in idiopathic thrombocytopenic purpura: a case report and literature
- Neutrophil extracellular traps - a potential trigger for the development of thrombocytopenia during extracorporeal membrane oxygenation
- Outcomes and Costs in Patients with Immune Thrombotic Thrombocytopenic Purpura Receiving Front-Line Versus Delayed Caplacizumab: A US Hospital Database Study
- Paediatric patients with suspected immune thrombotic thrombocytopenic purpura also experience treatment delays
- PD-1/PD-L1 inhibitor-induced immune thrombocytopenia: A pharmacovigilance study and systematic review
- Plasma cell-directed therapy strategies in immune-mediated thrombotic thrombocytopenic purpura (iTTP)
- Predicting the efficacy of glucocorticoids in pediatric primary immune thrombocytopenia using plasma proteomics
- Prednisone vs high-dose dexamethasone in newly diagnosed adult primary immune thrombocytopenia: a randomized trial
- Qualitative study of the consequences of vaccine-induced immune thrombocytopenia and thrombosis: the experiences of family members
- Real-world evidence confirms thrombopoietin receptor agonists are safe and effective for all stages of immune thrombocytopenia
- Recent advances in the management of immune thrombocytopenic purpura (ITP): A comprehensive review
- Regulatory role of ceRNA network in B lymphocytes of patients with immune thrombocytopenia
- Relapse of Ulcerative Colitis with Immune Thrombocytopenia and Pyoderma Gangrenosum Subsequent to Receiving COVID-19 Vaccination
- Retrospective evaluation of leflunomide as an adjunctive therapy in dogs with non-associative immune-mediated thrombocytopenia: 20 cases (2008-2021)
- Risk of fractures and use of bisphosphonates in adult patients with immune thrombocytopenia-A nationwide population-based study
- Risk of secondary autoimmune diseases with alemtuzumab treatment for multiple sclerosis: a systematic review and meta-analysis
- Risk-based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP)
- Romiplostim as an early treatment for refractory immune thrombocytopenia in a 2-month-old infant
- Should we consider caplacizumab as routine treatment for acute thrombotic thrombocytopenic purpura? An expert perspective on the pros and cons
- Simultaneous Bentall Procedure and Partial Atrioventricular Septal Defect Repair in a 64-Year-Old Patient with Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review
- Spontaneous Oral Purpura in Immune Thrombocytopenia
- Successful treatment with oseltamivir phosphate in children with ITP who failed first-line therapy: a case series report
- The evolution of preexisting primary immune thrombocytopenia after COVID-19 onset: A nationally representative, prospective, multicentre, observational study
- The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim
- The role of BAFF and BAFF-R inhibitors in the treatment of immune thrombocytopenia; a focused review
- The use of belimumab on patients with both systemic lupus erythematosus and immune thrombocytopenia: A retrospective cohort study
- Therapeutic strategies in FcγIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT)
- Thrombopoietin receptor agonist and rituximab combination therapy in patients with refractory primary immune thrombocytopenia
- Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada
- Thrombosis in patients with immune thrombocytopenia: incidence, risk, and clinical outcomes
- Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
- Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond
- Thrombotic complications of immune thrombocytopenic purpura
- TNFalpha-308G>A Polymorphism and Susceptibility to Immune Thrombocytopenia Purpura (ITP): Evidence From a Systematic Review and Meta-analysis
- Translating mechanisms into therapeutic strategies for immune thrombocytopenia (ITP): Lessons from clinical trials
- Treatment of critical bleeding events in patients with immune thrombocytopenia: a protocol for a systematic review and meta-analysis
- Use of human intravenous immunoglobulin for the treatment of 12 dogs with newly diagnosed malignant disease and presumed secondary immune-mediated thrombocytopenia
- Using saline bags instead of commercial retrieval bags to reduce the cost of splenic retrieval after laparoscopic splenectomy
- Vakzin-induzierte Immunthrombozytopenie und Thrombose: Langfristiger Outcome
- Where have all the platelets gone? HIT, DIC, or something else?